How many patents does
Purdue Pharma have?
patents
4,036
families
242
granted
1,047
applications
2,989
US
1,029
EP
423
JP
216
WO
137
CN
128
KR
93
GB
13
RoW
1,997
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Purdue Pharma
Top ten assignees appearing on patents
2009 - 2018
| purdue pharma | 2152 |
| euro-celtique | 1238 |
| shionogi & company | 249 |
| purdue pharmaceuticals | 175 |
| lts lohmann therapie-systeme | 132 |
| the p.f. laboratories | 121 |
| purdue pharma l. p. | 37 |
| vm pharma | 26 |
| mundipharma international | 25 |
| rhodes technologies | 23 |
Purdue Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic | 295 | 2006 |
| oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone | 149 | 2004 |
| pharmaceutical preparation containing oxycodone and naloxone | 96 | 2002 |
| pharmaceutical formulation containing gelling agent | 92 | 2001 |
| encased tamper resistant controlled release dosage forms | 85 | 2010 |
| tamper-resistant oral opioid agonist formulations | 83 | 2000 |
| once-a-day oxycodone formulations | 75 | 2001 |
| controlled release hydrocodone formulations | 72 | 2000 |
| systems and methods for treating an opioid-induced adverse pharmacodynamic response | 60 | 2012 |
| methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahy… 🛈 | 60 | 2004 |